Record growth, margin pressure—strategic mix shift or execution risk?

Margin fell 53% FY26 to 47% Q1 FY27; ECL ₹6.2 Cr accounts for only 2 pts; remaining 4 pts from deliberate low-margin mix (ancillary/cross-rental) and employee incentive, not quality collapse

Revenue +39% YoY confirmed; but QoQ PAT declined 5.1% (₹69 Cr to ₹65 Cr) despite +8% revenue growth, signaling execution/margin pressure

Confirmed; GCC income ₹19 Cr at 23% EBITDA margin in Q1, demonstrating early profitability despite higher DSO (201 days) and operational costs

Q1 showed 18% EBITDA margin before unallocated expenses; with allocation, drops to 10-12%. Management guidance: 12-15% going forward. Current show 11% reported, needs unallocated add-back to validate 15% ceiling claim

Guidance maintained, not raised. Implies only 20-30% EBITDA growth vs 40% top-line growth. Conservative for a high-growth story and signals margin headwinds may persist

53% FY26 → 47% Q1 FY27 (-6 pts). Management explains via ECL (2 pts) + forex (1 pt) + incentive (1 pt) + mix (2 pts), but underlying yield/pricing pressure evident: India 2.29% yield structural, KSA 4.1% shows capex at India-like returns may face headwinds

Prior FY26: 36.9% growth. Q1 FY27: 39% growth (beat). But FY27 guidance ₹525-575 Cr EBITDA implies only 20-30% growth vs 40% revenue growth. Margin expansion absent despite scale

DSO spike to 201 days attributed to US-Israel-Iran conflict; management confident temporary and deploying full ₹324 Cr capex (316 Cr revenue-generating). No delay assumed, but execution risk flagged via July collection recovery claim

Order book ₹686 Cr (up from ₹400 Cr prior year); inquiry ₹4.6 Cr. Management raising normalized margin guide to 12-15% vs prior 10-12%, citing execution scale & client mix. But pipeline largely unsecured; execution dependencies (client delays, OEM supply, local ROW) pose margin lumpiness risk

Saudi Arabia is not response to India. Both markets strong. KSA yields much higher (4.1% vs 2.29% India), utilization par, Vision 2030 backlog huge. India yields have improved, competition not capping. Deploying ₹190 Cr India, ₹200 Cr KSA based on order visibility & IRR criteria for group ROCE discipline.

Sangreen asset-light, lower margin but high ROCE; all capex stays in crane rental (₹652 Cr at 2% yield, 80% util). Blended EBITDA margin will be lower, but absolute EBITDA FY27 ₹525-575 Cr is 20-30% growth from FY26 ₹429 Cr. Complementary models.

US-Israel-Iran conflict caused disruption as of June quarter-end. Significant collections happened in July post-quarter; DSO will improve and show in Q2 results. Known factor when entering KSA. Zero working capital draw in Kingdom despite DSO, testament to business model.

₹686 Cr order book (not GW), ₹4,656 Cr inquiry pipeline. Doubled revenue 3 years running (₹250 Cr → ₹500 Cr); on track to double again FY27. ~15% order may slip to FY28 due project delays (client, OEM, POCM). FY28 guide: revenue +30-40%, EBITDA +20-30% (₹650-700 Cr).

18% is pre-unallocated; post allocation 10-12% currently. Going forward, E&C settle at 12-15%. Scale brings margin deprecation due execution delays (client site readiness, OEM supply, local ROW), but competitive moat (organized, governed, PE-backed clientele) supports premium pricing.

0.72 is gross, not net. Treasury surplus >₹300 Cr; net debt-to-equity range 0.3-0.7. ECL provision India-specific (aging receivables), expected to normalize as collections improve. No higher provisioning expected.

No structural changes to KSA hypothesis despite disruption. Temporary supply chain disruption, normalize within FY27. ₹316 Cr revenue-generating capex on order; no delay expected. Deploy Q3-Q4 offline for revenue. Confident in region, invested significant mgmt time.

Order book ₹1,250 Cr fully executable FY27; inquiry ₹5,600 Cr provides buffer. Based on capex deployment schedule (₹560 Cr H2 deployment), 15% revenue contribution assumed. Two-thirds crane rental, one-third renewables expected full-year mix

Implies blended margin 37-38%, below current crane 47%+ standalone. Reflects renewables (lower EBITDA%) and margin headwinds (ECL normalization, mix shift, KSA build-out, FX risk). No guidance on core crane margin recovery pathway or timeline

India ₹190 Cr, KSA ₹324 Cr, balance other. All capex revenue-generating. OEM delivery and project commissioning timelines being monitored; 15% FY27 revenue contribution from new fleet expected

Core crane EBITDA margin fell 600 bps YoY (53% → 47%) despite 39% revenue growth. Management attributes 4 pts to temporary (ECL, forex, incentive), 2 pts to deliberate mix shift. If underlying structural yield/pricing pressure persists, margin recovery to ₹525-575 Cr EBITDA guidance may not materialize

GCC (Middle East) DSO spiked to 201 days (vs India 124 days) due US-Israel-Iran conflict. Management claims July collections normalized DSO, but no evidence provided. Ongoing regional instability (West Asia disruptions) could extend collection cycles, tie up capital, and pressure cash flow

₹560 Cr capex deployment planned H2 FY27 depends on OEM delivery timelines and project commissioning. Management assumes 15% revenue contribution from new fleet FY27, but delays could push revenue into FY28. Sangreen POCM methodology adds revenue lumpiness risk (15% of order book ~₹100 Cr may slip to FY28 per management)

KSA EBITDA margin at 23% (vs India core 47%) due higher operational costs. Management claims margin will improve as experience grows, but no quantified recovery path or timeline given. If cost inflation (labor, fuel, maintenance) accelerates due regional economic pressures, KSA returns could underperform vs guidance

Sangreen targeting 12-15% normalized EBITDA margin, but currently showing 10-12% post unallocated expenses. Revenue recognition via POCM creates lumpiness. Management flagged execution delays (client site readiness, OEM supply, local ROW), internal delays, and project ramp timelines suppress margin. Scaling from ₹250 Cr (FY25) → ₹500 Cr (FY26) → ₹1,000 Cr+ (FY27) trajectory ambitious; margin delivery under execution uncertainty